siRNA: $12.7 billion in 2022 to an estimated $39.2 billion

[Tlexander]

Market forecasts suggest that the sector could expand from roughly $12.7 billion in 2022 to an estimated $39.2 billion by 2029, driven by advances in chemical modifications that improve molecule stability, target specificity, and in vivo durability.